A review of studies on the mode of action of clofibrate and betabenzalbutyrate.
D000217:Acyltransferases / Q000037:antagonists & inhibitors; D000067956:Adenylyl Cyclase Inhibitors; D000273:Adipose Tissue / Q000378:metabolism; D000418:Albumins / Q000378:metabolism; D000475:Alkenes / Q000494:pharmacology*; D000818:Animals; D002087:Butyrates / Q000494:pharmacology*; D002784:Cholesterol / Q000096:biosynthesis; D002994:Clofibrate / Q000494:pharmacology*; D003065:Coenzyme A; D005990:Glycerol / Q000378:metabolism; D005994:Glycerophosphates; D008025:Ligases / Q000378:metabolism; D050356:Lipid Metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology / Q000378:metabolism; D011485:Protein Binding; D051381:Rats; D013974:Thyroxine / Q000378:metabolism; D014280:Triglycerides / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism
D000067956:Adenylyl Cyclase Inhibitors; D000418:Albumins; D000475:Alkenes; D002087:Butyrates; D005994:Glycerophosphates; D014280:Triglycerides; D002784:Cholesterol; D000217:Acyltransferases; D008025:Ligases; D002994:Clofibrate; D005990:Glycerol; D013974:Thyroxine; D003065:Coenzyme A